Latest News & Features
Americas
“I have a message for all of you searching for a treatment and a cure in your lifetime; I hope you can look at my story and know that anything is possible,” said Ashanti DeSilva to attendees at the 2018 BIO International Convention. 6 June 2018
Americas
In 2007, Robin Roberts, co-anchor for ABC News’s Good Morning America show, was diagnosed with breast cancer. Five years later, she was diagnosed with myelodysplastic syndrome, a disease of the blood and bone marrow once known as pre-leukaemia. 6 June 2018
Americas
Why has the US Supreme Court never granted certiorari on the issue of differing standards required to prove patent invalidity at district courts and at the US Patent and Trademark Office (USPTO)? 6 June 2018
Americas
“It is my firm belief that folks on all sides need to stop relentlessly bashing the [patent] system if they want it to succeed.” 5 June 2018
Europe
C5’s International Pharma Patent Term Extensions Forum, which will be held in Munich, Germany on June 19 and 20, will provide guidance on patent term extensions in the world’s key IP regions, as LSIPR finds out. 4 June 2018
Asia
India’s Drug Technical Advisory Board, which advises the government, has reportedly approved a “track and trace” proposal that will allow Indian consumers to identify whether their medicine is genuine simply by sending a text message. 4 June 2018
Big Pharma
The Paris Court of First Instance has nullified a supplementary protection certificate covering Gilead’s HIV/AIDS treatment Truvada. 4 June 2018
Americas
Drug companies can take heart from a range of best practices in the battle against counterfeit medicines, as LSIPR finds out. 4 June 2018
Big Pharma
With Brexit looming, questions are being asked about the future regulatory relationship between the EU and the UK, with life sciences companies wondering how they will be affected. LSIPR reports. 4 June 2018
Americas
As innovation in the CRISPR field continues across the world, questions are being asked about the role of regulating such a powerful tool, while discussions around licensing the technology continue, as LSIPR reports. 4 June 2018